MALVERN, Pa., Sept. 15, 2016 -- Liberty Property Trust (NYSE:LPT) today announced that its board of trustees has declared a cash dividend of $0.475 per share on the company’s common shares of beneficial interest for the third quarter of 2016. The dividend will be payable on October 17, 2016 to shareholders of record on October 3, 2016.
About Liberty Property Trust
Liberty Property Trust (NYSE:LPT) is a leader in commercial real estate, serving customers in the United States and United Kingdom, through the development, acquisition, ownership and management of superior office and industrial properties. Liberty's 104 million square foot portfolio includes 684 properties which provide office, distribution and light manufacturing facilities to 1,600 tenants.
Inquiries: Jeanne Leonard, Liberty Property Trust, 610.648.1704


BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Apple Turns 50: From Garage Startup to AI Crossroads
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 



